Global Pharmaceutical Contract Packaging Market Outlook (2023 to 2033)

The global pharmaceutical contract packaging market is predicted to be valued at US$ 6.1 billion in 2023. Contract packaging services in pharmaceuticals are forecasted to advance at 7.5% CAGR from 2023 to 2033. By the end of the year 2033, the overall market is forecasted to reach a valuation of US$ 11.9 billion.

Pharmaceutical Contract Packaging Market Trends

  • Increasing demand for eco-friendly and reusable packaging regarding environmental degradation has surged the demand for sustainable pharmaceutical packaging.
  • A significant rise in the e-commerce industry allowing vendors to expand their business to a wider audience has also popularized pharmaceutical packaging and labeling.
  • Government agencies implement stricter norms on the packaging of medicines and other related chemicals to maintain quality.
  • Improving pharmaceutical packaging materials so that they can withstand adverse environmental conditions is a major priority for key players in most contract packaging markets.
  • A scale-oriented acquisition strategy owing to the merger between cloud packaging companies and their clientele is also promoting market growth.
Report Attributes or Data Points Details
Global Pharmaceutical Contract Packaging Market Size in 2022 US$ 5.6 billion
Estimated Global Market Share in 2023 US$ 6.1 billion
Forecasted Global Market Size by 2033 US$ 11.9 billion
Projected Global Market Growth Rate from 2023 to 2033 7.5% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Market Analysis during Historical Period from 2018 to 2022 Compared to Forecast Outlook for 2023 to 2033

Establishing mutually beneficial relationships with contract packaging organizations (CPOs) to avoid a lack of resources and budgets is driving the pharmaceutical contract packaging market growth. Furthermore, it is anticipated to rise with the implementation of serialization that mandates the barcodes and transfer of data in the supply of medicines.

The rising prevalence of atmosphere-sensitive pharmaceutical drugs has surged the demand for silica-based packaging material as the latest pharmaceutical contract packaging market trend. Moreover, a proliferation of the geriatric population in developed regions highly dependent on pharmaceutical drugs is projected to boost the sales of pharmaceutical contract packaging.

Key Pharmaceutical Contract Packaging Market Dynamics

New treatments such as gene and cell therapies, and growing demand for bio-products are some of the factors driving the adoption of pharmaceutical contract packaging. The capability of vendors to undertake several packaging projects, including sorting issues arising from complex packaging requirements surges the adoption of pharmaceutical contract packaging.

Government execution of new regulations to control the quality of pharmaceutical products available in the market is driving innovations in pharmaceutical product packaging and labeling. Generic pharmaceuticals of lower cost increasing in popularity and requiring efficient packaging and protection during storage and shipping is projected to boost the demand further.

Drawbacks in the Pharmaceutical Contract Packaging

Fluctuating prices of raw materials used for manufacturing pharmaceutical packaging products are some of the factors anticipated to hamper the market growth. Increasing risks associated with the poor quality of the product as well as design could also compromise the credibility of the pharmaceutical packaging market.

The availability of counterfeit medicines containing false or inactive ingredients across the globe significantly hinders the growth opportunity for the pharmaceutical packaging industry. On top of that, the lack of expertise of employees for effective in-house packaging capabilities, and budget constraints further obstruct the outsourcing trends in pharmaceutical packaging.

Comparative View of the Adjacent Pharmaceutical Contract Packaging Market

Convenience of contract packaging of pharmaceutical products has increased demand for third-party operators globally as well as in several regions. The data and trends that are now driving the markets for contract packaging in several other industries are shown in the table below. Assessing the emerging trends and opportunities in contract packaging and FMCG packaging markets may make it simpler to see how industries are performing nowadays.

Pharmaceutical Contract Packaging Market:

Attributes Pharmaceutical Contract Packaging Market
CAGR (2023 to 2033) 7.5%
Market Value (2023) US$ 6.1 billion
Growth Factor The rising prevalence of diseases such as diabetes asthma and other chronic diseases is due to the growing aging population.
Future Opportunities Higher spending in public healthcare systems and health awareness could drive the sales of pharmaceuticals and active formulations.
Market Trends Pharmaceutical companies are adopting contract packaging solutions, enabling service providers to operate the packaging line accordingly.

Contract Packaging Market:

Attributes Contract Packaging Market
CAGR (2023 to 2033) 5.2%
Market Value (2023) US$ 46.5 billion
Growth Factor Burgeoning businesses and startups throughout the world as well as the requirement for a systematic and structured packaging line.
Future Opportunities The growing use of outsourced packaging services to speed up packaging and value addition while also extending the supply chain.
Market Trends Prominent layers now offer geographic assistance and, a simple operating flow, and allow the firms to concentrate on their core competencies.

FMCG Packaging Market:

Attributes FMCG Packaging Market
CAGR (2023 to 2033) 5.8%
Market Value (2023) US$ 443.1 billion
Growth Factor The adoption of barcodes, QR codes, and temperature and moisture indicators through packaging eventually speeds up purchasing choices.
Future Opportunities Intelligent packaging solutions are getting popular more day by day as they provide value-added experiences to customers.
Market Trends Numerous end users, including F&B and the pharmaceutical industry, are shifting from conventional packaging formats to smart packaging.
Ismail Sutaria
Ismail Sutaria

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

United States Dominates the Total Business of Pharmaceutical Packaging in North America

North America accounts for the leading market share by generating almost one-third of the global demand for effective pharmaceutical packaging solutions through contracts. The total revenue generated by the United States alone was figured out to be around 90% of the total business in North America.

Quality services offered by the CPOs and CDMOs based in the United States propel the demand for pharmaceutical contract packaging services and solutions in the country. The demand for biological therapies, increase in strict protocols, and rise in the geriatric population could also broaden the global pharma contract packaging market size.

Germany to Make Way for the Establishment of More Pharmaceutical Packaging Industries

Europe holds a 28% revenue in the pharmaceutical contract packaging market share and is the second most dominating market. Germany was figured out to be leading in terms of the production of assets for the establishment of pharmaceutical contract packaging industries. Over the years from 2023 to 2033, the regional market is expected to advance at a rate of 5% per year.

A large presence of major manufacturers operating in the pharmaceutical industry creates lucrative opportunities and increases the adoption of pharmaceutical contract packaging. Increasing the use of plastic bottles and containers, vials & ampoules, and pre-fillable syringes could also boost the demand for pharmaceutical contract packaging in this region.

China to Dominate the Growing Pharmaceutical Packaging Market in Asia

The Asia Pacific is anticipated to grow at a remarkable CAGR in pharmaceutical contract packaging services and products in the coming days. China is the leading market hear that is poised to exhibit a year-on-year increment of 8.7% from 2023 to 2033.

Increasing demand for biological therapies and rigid protocols associated with packaging processes have created a huge demand for outsourced pharmaceutical packaging in the country. In addition to this, the presence of several pharmaceutical contract packaging service providers in the region has boosted the overall market size in the past.

India to Experience Some Lucrative Growth Opportunities

The sales of pharmaceutical contract packaging are anticipated to rise owing to the rapid outsourcing of pharmaceutical manufacturing to emerging countries, such as India. India, in particular, is anticipated to exhibit a lucrative growth rate of 9.1% over the forecast years.

In the table below we have represented the regional growth rates of different countries in pharmaceutical contract packaging. Though the countries in North America and Europe lead the global business, the emerging economies promise greater opportunities in this industry.

Regional Market Comparison CAGR (2023 to 2033)
United States 4.8%
Germany 5%
United Kingdom 6.4%
India 9.1%
China 8.7%

Category-wise Insights

Plastic or Glass Containers are the Most Preferred Material in the Industry

The use of plastic and glass is projected to rise owing to the increasing utilization of smart pharmaceutical packaging solutions such as smart labels. Furthermore, research and development activities to develop advanced plastics and 3D-printing devices are also expected to drive the use of plastic containers in the future.

Attributes Details
Top Packaging Type Plastic or Glass Container
Market Share in 2023 82.9%

Injectable Packaging Form is Making New Inroads in the Overall Market

Based on different forms of packaging, the demand for injectable packaging forms acquires a higher share of the global pharmaceutical market. Stakeholders are re-shuffling their production activities to adapt to the demands of the healthcare infrastructures and are encouraging further innovations in pharmaceutical product packaging. Also, the increasing consumer interest in innovative packaging fuels the demand for emerging trends in pharmaceutical contract packaging.

Attributes Details
Top Form Type Injectable
Market Share in 2023 61.9%

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Start-up Ecosystem in the Pharmaceutical Contract Packaging

To protect pharmaceutical products better than conventional materials, startups in pharmaceutical contract packaging strive to develop enhanced packaging solutions. This is changing the landscape of pharmaceutical contact packaging and generating newer and more innovative ideas to tackle every challenge.

Hence, some start-up companies such as Veneti, Unipharm Healthy Manufacturing, V-Shapes, Blistr, Calyx Containers, etc. are coming up with various strategies to scale their business. They are mostly resorting to novel solutions like medical cannabis containers, biodegradable pharma packaging, single-portion packets, contract pharmaceutical packaging with labeling and distribution, etc.

Some of the key players in the pharmaceutical contract packaging market are

  • Catalent Pharma Solutions
  • Patheon
  • Baxter BioPharma Solutions
  • AbbVie Contract Manufacturing
  • Pfizer Centre Source
  • Daito Pharmaceutical
  • Nipro Corporation
  • Becton Dickinson & Company
  • AptarGroup Inc.
  • Drug Plastics Group
  • Gerresheimer AG
  • Schott AG
  • Owens Illinois Inc.
  • WestRock Company SGD S.A.
  • International Paper Company
  • COMAR LLC
  • CCL Industries Inc.
  • Vetter Pharma International
  • Adelphi Healthcare Packaging
  • Sharp Corporation
  • Amcor Limited
  • Berry Plastics Corporation
  • MeadWestvaco Corporation
  • Becton Dickinson and Company
  • Owens-Illinois Inc.
  • West Pharmaceuticals Services Inc.
  • Schott Pharmaceuticals Services Inc.
  • RPC Group Plc
  • Graphic Packaging International Inc.

Some of the recent developments in pharmaceutical contract packaging are

  • In January 2021, Nelipak Laboratory Services completed the collaboration of a new climatic conditioning compartment to meet the amplified demand for conditioning.
  • In December 2020, ProAmpac acquired Rosenbloom Groupe Inc., Hymopack Ltd., and Dyne-A-Pak, based in Canada that manufacture packaging products, to enhance the manufacturing capabilities of the company.
  • In May 2021, Sharp - a clinical services company owned by UDG Healthcare plc, purchased new land as part of a US$ 17 million investment in its Conshohocken, PA, to add future capacity for cGMP packaging services.
  • In June 2020, PCI Pharma announced a partnership agreement with Experic, to explore clinical and commercial manufacturing, packaging, and supply chain services driving collective growth for both parties.

Pharmaceutical Contract Packaging Market Report Scope

Report Attribute Details
Growth Rate CAGR of 7.5% from 2023 to 2033
The base year for estimation 2022
Historical data 2018 to 2022
Forecast period 2023 to 2033
Quantitative units Revenue in US$ million or billion and CAGR from 2022 to 2032
Report Coverage Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis,
Segments Covered By Type, By Form, By Application, and By Region.
Regional scope North America; Western Europe, Eastern Europe, Middle East and Africa (MEA), ASEAN, South Asia, Rest of Asia, Australia, and New Zealand
Country scope United States of America; Canada; Mexico; Germany; United Kingdom; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa
Key companies profiled Catalent Pharma Solutions, Patheon, Baxter BioPharma Solutions, AbbVie Contract Manufacturing, Pfizer Centre Source, Daito Pharmaceutical, Nipro Corporation, Becton Dickinson & Company, AptarGroup Inc., Drug Plastics Group, Gerresheimer AG, Schott AG, Owens Illinois Inc., WestRock Company SGD S.A., International Paper Company, COMAR LLC, CCL Industries Inc., Vetter Pharma International, Adelphi Healthcare Packaging, Sharp Corporation, Amcor Limited, Berry Plastics Corporation, MeadWestvaco Corporation, Becton Dickinson and Company, Owens-Illinois Inc., West Pharmaceuticals Services Inc., Schott Pharmaceuticals Services Inc., RPC Group Plc, Graphic Packaging International Inc., etc.
Customization scope Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options Avail customized purchase options to meet your exact research needs.

Pharmaceutical Contract Packaging Market Segmentation

By Product Type:

  • Flexible Packaging
  • Plastic or Glass Containers
  • Caps or Closures

By Form Type:

  • Oral
  • Injectable

By Application Type:

  • Autacoids & Related Drugs
  • Contraceptives
  • Hormone Replacement
  • Cardiovascular Medicines
  • Cancer Therapies

By Region:

  • North America Market
  • Latin America Market
  • Asia Pacific Market
  • Middle East and Africa (MEA) Market
  • Europe Market

Frequently Asked Questions

How Big is the Global Pharmaceutical Contract Packaging Market?

The global pharmaceutical contract packaging market value was US$ 5.6 billion in 2022.

What is the Pharmaceutical Contract Packaging Market Trend for the Future?

The pharmaceutical contract packaging market is likely to follow a 7.5% CAGR through 2033

Who are the Leading Pharmaceutical Contract Packaging Solution Providers?

Catalent, Patheon, Baxter, and AbbVie are the leading market players currently.

Which Country is the Dominant Shareholder in North America?

The United States accounts for nearly 90% revenue share of the North America market.

Which Country to Witness Higher Growth Rate in the Future?

India could exhibit a 9.1% CAGR in pharmaceutical contract packaging through 2033.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033

        5.3.1. Flexible Packaging

        5.3.2. Plastic/Glass Containers

        5.3.3. Caps/Closures

    5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Form, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Form, 2023 to 2033

        6.3.1. Oral

        6.3.2. Injectable

    6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        7.3.1. Autacoids & Related Drugs

        7.3.2. Contraceptives

        7.3.3. Hormone Replacement

        7.3.4. Cardiovascular Medicines

        7.3.5. Cancer Therapies

    7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Type

        9.2.3. By Form

        9.2.4. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By Form

        9.3.4. By Application

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Type

        10.2.3. By Form

        10.2.4. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By Form

        10.3.4. By Application

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Type

        11.2.3. By Form

        11.2.4. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By Form

        11.3.4. By Application

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Type

        12.2.3. By Form

        12.2.4. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By Form

        12.3.4. By Application

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Type

        13.2.3. By Form

        13.2.4. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By Form

        13.3.4. By Application

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Type

        14.2.3. By Form

        14.2.4. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By Form

        14.3.4. By Application

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Type

        15.2.3. By Form

        15.2.4. By Application

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Type

        15.3.3. By Form

        15.3.4. By Application

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Type

            16.1.2.2. By Form

            16.1.2.3. By Application

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Type

            16.2.2.2. By Form

            16.2.2.3. By Application

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Type

            16.3.2.2. By Form

            16.3.2.3. By Application

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Type

            16.4.2.2. By Form

            16.4.2.3. By Application

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Type

            16.5.2.2. By Form

            16.5.2.3. By Application

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Type

            16.6.2.2. By Form

            16.6.2.3. By Application

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Type

            16.7.2.2. By Form

            16.7.2.3. By Application

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Type

            16.8.2.2. By Form

            16.8.2.3. By Application

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Type

            16.9.2.2. By Form

            16.9.2.3. By Application

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Type

            16.10.2.2. By Form

            16.10.2.3. By Application

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Type

            16.11.2.2. By Form

            16.11.2.3. By Application

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Type

            16.12.2.2. By Form

            16.12.2.3. By Application

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Type

            16.13.2.2. By Form

            16.13.2.3. By Application

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Type

            16.14.2.2. By Form

            16.14.2.3. By Application

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Type

            16.15.2.2. By Form

            16.15.2.3. By Application

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Type

            16.16.2.2. By Form

            16.16.2.3. By Application

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Type

            16.17.2.2. By Form

            16.17.2.3. By Application

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Type

            16.18.2.2. By Form

            16.18.2.3. By Application

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Type

            16.19.2.2. By Form

            16.19.2.3. By Application

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Type

            16.20.2.2. By Form

            16.20.2.3. By Application

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Type

            16.21.2.2. By Form

            16.21.2.3. By Application

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Type

            16.22.2.2. By Form

            16.22.2.3. By Application

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Type

            16.23.2.2. By Form

            16.23.2.3. By Application

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Type

        17.3.3. By Form

        17.3.4. By Application

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Catalent Pharma Solutions

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Patheon

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Baxter BioPharma Solutions

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. AbbVie Contract Manufacturing

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Pfizer CentreSource

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Daito Pharmaceutical

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. Nipro Corporation

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Becton Dickinson & Company

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. AptarGroup Inc

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. Drug Plastics Group

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. Gerresheimer AG

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Packaging

Anti-counterfeit Pharmaceutical Packaging Market

February 2022

REP-GB-2385

October 2023

189 pages

Packaging

Pharmaceutical Vials Market

July 2021

REP-GB-5859

February 2023

328 pages

Explore Packaging Insights

View Reports
Future Market Insights

Pharmaceutical Contract Packaging Market